SUVENPHAR Suven Pharmaceuticals Ltd Company Mergers Announcement 2024 - NJ Bio Acquisition Suven Pharmaceuticals has acquired a 56% stake in NJ Bio, Inc. for $64.4 million to enhance its position in the ADC market, which is projected to grow rapidly..Find Corporate Announcements for Press Releases, AGM, Insider Trading & SAST, Results and Corporate Action for Suven Pharmaceuticals Ltd